胰高血糖素样肽1信号通路在神经系统中的作用及其潜在的神经保护作用是什么？ - Suppr | 超能文献

What Is the Role of Glucagon-Like Peptide 1 Signaling in the Nervous System and Its Potential Neuroprotective Effects?

作者信息

Turcano Pierpaolo, Savica Rodolfo, Benarroch Eduardo

机构信息

From the Mayo Clinic, Rochester, MN.

出版信息

Neurology. 2024 Aug 27;103(4):e209781. doi: 10.1212/WNL.0000000000209781. Epub 2024 Jul 30.

DOI:10.1212/WNL.0000000000209781

Abstract

摘要

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

文档翻译

学术文献翻译模型，支持多种主流文档格式。

相似文献

1

What Is the Role of Glucagon-Like Peptide 1 Signaling in the Nervous System and Its Potential Neuroprotective Effects?胰高血糖素样肽1信号通路在神经系统中的作用及其潜在的神经保护作用是什么？

Neurology. 2024 Aug 27;103(4):e209781. doi: 10.1212/WNL.0000000000209781. Epub 2024 Jul 30.

2

New insights into the effects of glucagon-like peptide-1 on heart rate and sinoatrial node function.胰高血糖素样肽-1对心率和窦房结功能影响的新见解。

Cardiovasc Res. 2024 Oct 14;120(12):1367-1368. doi: 10.1093/cvr/cvae150.

3

Glucagon-like peptide-1 receptor.胰高血糖素样肽-1受体

Curr Biol. 2024 Dec 2;34(23):R1163-R1164. doi: 10.1016/j.cub.2024.10.039.

4

Beyond insulin: The Intriguing role of GLP-1 in Parkinson's disease.超越胰岛素：GLP-1 在帕金森病中的有趣作用。

Eur J Pharmacol. 2024 Nov 5;982:176936. doi: 10.1016/j.ejphar.2024.176936. Epub 2024 Aug 23.

5

Peptidic exenatide and herbal catalpol mediate neuroprotection via the hippocampal GLP-1 receptor/β-endorphin pathway.肽类艾塞那肽和中药梓醇通过海马GLP-1受体/β-内啡肽途径介导神经保护作用。

Pharmacol Res. 2015 Dec;102:276-85. doi: 10.1016/j.phrs.2015.10.008. Epub 2015 Nov 3.

6

Novel GLP-1R/GIPR co-agonist "twincretin" is neuroprotective in cell and rodent models of mild traumatic brain injury.新型胰高血糖素样肽-1受体/葡萄糖依赖性促胰岛素多肽受体双重激动剂“双cretin”在轻度创伤性脑损伤的细胞和啮齿动物模型中具有神经保护作用。

Exp Neurol. 2017 Feb;288:176-186. doi: 10.1016/j.expneurol.2016.11.005. Epub 2016 Nov 11.

7

Activation of Glucagon-Like Peptide-1 Receptor Promotes Neuroprotection in Experimental Autoimmune Encephalomyelitis by Reducing Neuroinflammatory Responses.胰高血糖素样肽-1 受体的激活通过减轻神经炎症反应促进实验性自身免疫性脑脊髓炎的神经保护作用。

Mol Neurobiol. 2018 Apr;55(4):3007-3020. doi: 10.1007/s12035-017-0550-2. Epub 2017 Apr 29.

8

Beyond metformin: The promise of glucagon-like peptide-1 receptor agonists for neuroprotection in Parkinson's disease.

Clin Nutr ESPEN. 2024 Oct;63:184-185. doi: 10.1016/j.clnesp.2024.06.034. Epub 2024 Jun 25.

9

Glucagon-like peptide-1 regulates mitochondrial biogenesis and tau phosphorylation against advanced glycation end product-induced neuronal insult: Studies in vivo and in vitro.胰高血糖素样肽-1调节线粒体生物合成并对抗晚期糖基化终产物诱导的神经元损伤的tau磷酸化：体内和体外研究

Neuroscience. 2015 Aug 6;300:75-84. doi: 10.1016/j.neuroscience.2015.05.023. Epub 2015 May 15.

10

Glucagon like peptide-1 (GLP-1) agonists and cardiometabolic protection: historical development and future challenges.胰高血糖素样肽-1（GLP-1）激动剂与心脏代谢保护：历史发展与未来挑战

Cardiovasc Diabetol. 2025 Jan 29;24(1):44. doi: 10.1186/s12933-025-02608-9.

引用本文的文献

1

Use of GLP-1 Receptor Agonists for the Management of Type 1 Diabetes: A Pediatric Perspective.胰高血糖素样肽-1受体激动剂在1型糖尿病管理中的应用：儿科视角

Horm Res Paediatr. 2025;98(4):405-424. doi: 10.1159/000541228. Epub 2024 Sep 2.